Researchers say more study is needed, but early results suggest the century-old vaccine could become a powerful new tool in ...

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

In the course of investigating the use of Bacillus Calmette-Guérin for high-risk individuals who have type 1 diabetes (T1D), researchers hoped—and found—that BCG could substantially reduce the chance ...

This diagram illustrates the timeline and current status of various TB vaccine candidates in clinical trials, highlighting the diversity of vaccine types and their potential impact on TB prevention ...

A recent Npj Vaccines study discussed the success and challenges of developing different tuberculosis (TB) vaccine types. Study: Key advances in vaccine development for tuberculosis—success and ...

Researchers headed by a team at Pitt University, in collaboration with scientists at Cornell University, have developed a self-destructing, intravenous (i.v.) Bacillus Calmette-Guérin (BCG) vaccine ...

Immunotherapy is an innovative way to harness the power of the body's immune system to fight threats like cancer. Normally, our immune system can detect and destroy abnormal cells on its own. But when ...

There is no highly effective vaccine against tuberculosis (TB), which remains an infection of global concern. Charles Kyriakos Vorkas, MD, an infectious diseases physician-scientist at the Renaissance ...

LITTLE ROCK, Ark. — The National Institutes of Health (NIH) has awarded UAMS researchers $3.7 million to pursue a possible breakthrough in tuberculosis (TB) research. While we may not see much TB in ...

The approval marks the start of human testing for the experimental vaccine, which is designed to strengthen immune protection in respiratory tract.